Your request to link to rcsb for Retinoic acid receptor beta

• 1DKF: crystal structure of a heterodimeric complex of rar and rxr ligand- binding domains (10.1016/S1097-2765(00)80424-4 )
• 1DSZ: structure of the rxr/rar dna-binding domain heterodimer in complex with the retinoic acid response element dr1 (10.1093/EMBOJ/19.5.1045 )
• 1EXA: enantiomer discrimination illustrated by crystal structures of the human retinoic acid receptor hrargamma ligand binding domain: the complex with the active r-enantiomer bms270394. (10.1073/PNAS.97.12.6322 )
• 1EXX: enantiomer discrimination illustrated by crystal structures of the human retinoic acid receptor hrargamma ligand binding domain: the complex with the inactive s-enantiomer bms270395. (10.1073/PNAS.97.12.6322 )
• 1FCX: isotype selectivity of the human retinoic acid nuclear receptor hrar: the complex with the rargamma-selective retinoid bms184394 (10.1006/JMBI.2000.4032 )
• 1FCY: isotype selectivity of the human retinoic acid nuclear receptor hrar: the complex with the rarbeta/gamma-selective retinoid cd564 (10.1006/JMBI.2000.4032 )
• 1FCZ: isotype selectivity of the human retinoic acid nuclear receptor hrar: the complex with the panagonist retinoid bms181156 (10.1006/JMBI.2000.4032 )
• 1FD0: isotype selectivity of the human retinoic acid nuclear receptor hrar: the complex with the rargamma-selective retinoid sr11254 (10.1016/S0969-2126(02)00828-6 )
• 1HRA: the solution structure of the human retinoic acid receptor- beta dna-binding domain (10.1007/BF00242472 )
• 1XAP: structure of the ligand binding domain of the retinoic acid receptor beta (10.1038/SJ.EMBOR.7400235 )
• 1XDK: crystal structure of the rarbeta/rxralpha ligand binding domain heterodimer in complex with 9-cis retinoic acid and a fragment of the trap220 coactivator (10.1074/JBC.M409302200 )
• 2LBD: ligand-binding domain of the human retinoic acid receptor gamma bound to all-trans retinoic acid (10.1038/378681A0 )
• 3A9E: crystal structure of a mixed agonist-bound rar-alpha and antagonist- bound rxr-alpha heterodimer ligand binding domains (10.1371/JOURNAL.PONE.0015119 )
• 3KMR: crystal structure of raralpha ligand binding domain in complex with an agonist ligand (am580) and a coactivator fragment (10.1038/NSMB.1855 )
• 3KMZ: crystal structure of raralpha ligand binding domain in complex with the inverse agonist bms493 and a corepressor fragment (10.1038/NSMB.1855 )
• 3LBD: ligand-binding domain of the human retinoic acid receptor gamma bound to 9-cis retinoic acid (10.1038/NSB0398-199 )
• 4DM6: crystal structure of rarb lbd homodimer in complex with ttnpb (10.1073/PNAS.1118192109 )
• 4DM8: crystal structure of rarb lbd in complex with 9cis retinoic acid (10.1073/PNAS.1118192109 )
• 4DQM: revealing a marine natural product as a novel agonist for retinoic acid receptors with a unique binding mode and antitumor activity (10.1042/BJ20120726 )
• 4JYG: crystal structure of rarbeta lbd in complex with agonist bms411 [4- {[(5,5-dimethyl-8-phenyl-5,6-dihydronaphthalen-2-yl) carbonyl]amino}benzoic acid] (10.1371/JOURNAL.PONE.0123195 )
• 4JYH: crystal structure of rarbeta lbd in complex with selective agonist bms948 [4-{[(8-phenylnaphthalen-2-yl)carbonyl]amino}benzoic acid] (10.1371/JOURNAL.PONE.0123195 )
• 4JYI: crystal structure of rarbeta lbd in complex with selective partial agonist bms641 [3-chloro-4-[(e)-2-(5,5-dimethyl-8-phenyl-5,6- dihydronaphthalen-2-yl)ethenyl]benzoic acid] (10.1371/JOURNAL.PONE.0123195 )
• 4LBD: ligand-binding domain of the human retinoic acid receptor gamma bound to the synthetic agonist bms961 (10.1038/NSB0398-199 )
• 5K13: crystal structure of the rar alpha ligand-binding domain in complex with an antagonist (10.1016/J.BMCL.2016.05.056 )
• 5M24: rarg mutant-s371e (10.1371/JOURNAL.PONE.0171043 )
• 5UAN: crystal structure of multi-domain rar-beta-rxr-alpha heterodimer on dna (10.1038/S41467-017-00981-Y )
• 6SSQ: crystal structure of rarbeta lbd in complex with lg 100754 (10.3390/CELLS8111392 )
• 6XWG: crystal structure of the human rxr/rar dna-binding domain heterodimer bound to the human rarb2 dr5 response element (10.1093/NAR/GKAA697 )
• 7AOS: crystal structure of the raralpha/rxralpha ligand binding domain heterodimer in complex with a fragment of src1 coactivator (10.1016/J.JMB.2021.166899 )
• 7APO: crystal structure of raralpha ligand binding domain in complex with a fragment of the tif2 coactivator (10.1016/J.JMB.2021.166899 )